Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00307788 · ClinicalTrials.gov registry record · Phase 3
Acupuncture Analgesia in Relation to Psychiatric Comorbidity
A Phase 3 study of Low Back Pain, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT00307788 is a Phase 3 study of Low Back Pain that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 60 participants, below the 503-participant average among 122 other Low Back Pain trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00307788, a Phase 3 study of Low Back Pain, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
It is our hypothesis that patient's expectations concerning treatment outcome will be influenced by their psychiatric symptoms, and that this expectancy will have a strong influence on the efficacy of acupuncture treatment to suppress experimentally induced pain. We will conduct a study, monitoring expectations but not manipulating them, in a cohort of patients with chronic low back pain.
Conditions Studied
Interventions
- PROCEDURE acupuncture
Study Locations (1)
Massachusetts
- Pain Management Center - Chestnut Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2004-05 |
| Est. Completion | 2010-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00307788
The ClinicalTrials.gov registry entry for NCT00307788 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 503-participant average among 122 other Low Back Pain trials with a reported enrollment target (88% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Low Back Pain appearing as the primary indexed condition, and to 1 intervention - of which acupuncture is the first listed.
NCT00307788 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00307788 about?
NCT00307788 is a clinical study titled "Acupuncture Analgesia in Relation to Psychiatric Comorbidity". It is our hypothesis that patient's expectations concerning treatment outcome will be influenced by their psychiatric symptoms, and that this expectancy will have a strong influence on the efficacy of acupuncture treatment to suppress experimentally induced pain. We will conduct a study, monitoring ...
What is the current status of trial NCT00307788?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 60 participants. The study started on 2004-05. Estimated completion is 2010-05.
What conditions does trial NCT00307788 study?
This clinical trial studies the following conditions: Low Back Pain.
What interventions are being tested in trial NCT00307788?
The interventions under investigation include: acupuncture (PROCEDURE).
Who is sponsoring clinical trial NCT00307788?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00307788 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Low Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nonpharmacologic Pain Management in FQHC Primary Care Clinics
RECRUITING · Phase 3
-
The Use of Methylsulfonylmethane (MSM) in the Treatment of Low Back Pain
COMPLETED · Phase 3
-
Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain
COMPLETED · Phase 3
-
Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain
COMPLETED · Phase 3
-
Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Experienced Subjects
COMPLETED · Phase 3
-
Osteopathic Health Outcomes in Chronic Low Back Pain (OSTEOPATHIC) Trial
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.